May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Macrophage Depletion Inhibits Experimental Choroidal Neovascularization
Author Affiliations & Notes
  • E. Sakurai
    Department of Ophthalmology, University of Kentucky, Lexington, KY, United States
  • A. Anand
    Department of Ophthalmology, University of Kentucky, Lexington, KY, United States
  • B.K. Ambati
    Department of Ophthalmology, Medical College of Georgia, Augusta, GA, United States
  • N. van Rooijen
    Department of Cell Biology & Immunology,, Vrije Universiteit, Amsterdam, Netherlands
  • J. Ambati
    Department of Cell Biology & Immunology,, Vrije Universiteit, Amsterdam, Netherlands
  • Footnotes
    Commercial Relationships  E. Sakurai, None; A. Anand, None; B.K. Ambati, None; N. van Rooijen, Roche Pharmaceuticals C, P; J. Ambati, None.
  • Footnotes
    Support  FFB Career Development Award, FFS/PBA Grant in Aid, U. of KY Physician Scientist Award (JA)
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 3946. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      E. Sakurai, A. Anand, B.K. Ambati, N. van Rooijen, J. Ambati; Macrophage Depletion Inhibits Experimental Choroidal Neovascularization . Invest. Ophthalmol. Vis. Sci. 2003;44(13):3946.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To investigate the role of macrophages in the development of choroidal neovascularization (CNV) using liposomal clodronate (Cl2MDP), a selective macrophage depleting agent. Methods: Laser photocoagulation was used to induce CNV in wild-type C57BL/6J mice. Mice were treated with intravenous and/or subconjunctival Cl2MDP or PBS at the following time points with respect to laser injury: 2 days before, immediately after, 2 days before & immediately after, or 2 days after. Macrophages were identified by immunostaining for F4/80. CNV responses were compared on the basis of en masse volumetric measurements and fluorescein angiography at 1 week following laser photocoagulation. Vascular endothelial growth factor (VEGF) expression was quantified by ELISA. Results: The site of laser injury is invaded by macrophages within 2 days of photocoagulation. Combined intravenous and subconjunctival Cl2MDP treatment 2 days before laser injury decreased CNV volume by 90.8 ± 3.1% (P < 0.0001), by 79.2 ± 11.1% (P < 0.0001) immediately after laser injury, volume by 91.7 ± 4.7% (P < 0.0001) before & immediately after laser injury, by 26.3 ± 17.9% (P = 0.11) 2 days after laser injury. Subconjunctival Cl2MDP treatment significantly decreased lesion volume when co-administered with intravenous PBS but did not confer added benefit to intravenous Cl2MDP. Significantly fewer lesions exhibited pathologically significant fluorescein leakage in groups treated before and/or immediately after injury with Cl2MDP. Treatment induced reduction in lesion volumes were correlated with VEGF protein levels and numbers of macrophages. Conclusions: Generalized macrophage depletion by Cl2MDP reduced the size and leakage of laser-induced CNV, and was associated with decreased numbers of macrophages and VEGF protein. These findings define the role of the macrophage as a critical component for initiation of the laser-induced CNV response.

Keywords: age-related macular degeneration • choroid: neovascularization • inflammation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×